Clinical Trial

Metronidazole as Preoperative Therapy in CRC / FusoMetro-001

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The proposed proof-of concept trial aims at determining the effectiveness of metronidazole in decreasing the Fusobacterium nucleatum load in tissues and possibly on its detrimental effects on tumor cells and tumor microenvironment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-02-17; most recent amendment 2025-11-14.
Status change: Not Yet Recruiting → Recruiting 2023-10-20
Trial Details
NCT Number NCT05748145
Lead Sponsor Oncology Institute of Southern Switzerland
Conditions Colorectal Cancer
Enrollment 40 participants
Start Date 2023-09-11
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-18